American Society of Hematology (ASH) Annual Meeting, December 9 –12, 2023

Zasoby na tej stronie

Pobierz zasoby

• plik pdf

  Safety and Efficacy Results from CLI120-001 a Phase 1 Study in RR-AML and HRMDS: Update from Higher Dose Levels

  Pobierz
• plik pdf

  Preclinical and Clinical Evidence for Erythroid-Stimulating Activity of RVU120 CDK8/19 Inhibitor in AML and MDS

  Pobierz
• plik pdf

  Novel Clinically Useful Inhibitor of Mediator Complex, RVU120, Relieves Differentiation Block in MDS/AML

  Pobierz
• plik pdf

  Targeting CDK8/CDK19 to Disrupt Leukemic Stem Cell-like Population in Acute Myeloid Leukemia: Exploring RVU120 As a Promising Frontline Therapy

  Pobierz
• plik pdf

  Mediator Kinase/CDK8 Inhibition as a Strategy to Improve FLT3 Inhibitor Activity in Acute Myeloid Leukemia

  Pobierz